A Phase II Randomized Controlled Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients (IIIb-IIIc)
Phase of Trial: Phase II
Latest Information Update: 25 Dec 2015
At a glance
- Drugs Capecitabine (Primary) ; Docetaxel (Primary) ; Oxaliplatin
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 03 Nov 2015 Planned End Date changed from 1 May 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 03 Nov 2015 Planned primary completion date changed to 1 Nov 2015 as reported by ClinicalTrials.gov record.
- 19 Jun 2012 New trial record